-
Signature
-
/s/ Jonathan V. Dixon, Attorney-in-Fact
-
Issuer symbol
-
BNGO
-
Transactions as of
-
17 Feb 2026
-
Net transactions value
-
-$22
-
Form type
-
4
-
Filing time
-
18 Feb 2026, 16:26:55 UTC
Quoteable Key Fact
"Mark Oldakowski filed Form 4 for Bionano Genomics, Inc. (BNGO) on 18 Feb 2026."
Quick Takeaways
- This page summarizes Mark Oldakowski's Form 4 filing for Bionano Genomics, Inc. (BNGO).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 18 Feb 2026, 16:26.
What Changed
- Previous filing in this sequence was filed on 04 Feb 2026.
- Current net transaction value: -$22.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| OLDAKOWSKI MARK |
CHIEF OPERATING OFFICER |
C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO |
/s/ Jonathan V. Dixon, Attorney-in-Fact |
18 Feb 2026 |
0001745566 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BNGO |
Common Stock |
Tax liability |
$22 |
-20 |
-2.2% |
$1.10 |
895 |
17 Feb 2026 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses: